These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 8708427)

  • 1. Lipoprotein(a) and general risk factors in patients with angiographically assessed peripheral arterial disease.
    Prior M; Arosio E; Ferrari M; Lucchese L; Guidi GC; Bosello O
    Int Angiol; 1995 Dec; 14(4):357-63. PubMed ID: 8708427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical risk factors for cardiovascular disease in an aged male population: emerging vascular pathogens.
    Lippi G; Arosio E; Prior M; Guidi G
    Angiology; 2001 Oct; 52(10):681-7. PubMed ID: 11666132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Risk status of patients with peripheral arterial disease (PAD)].
    Jassó I; Landi A; Dinya E
    Orv Hetil; 2007 Dec; 148(52):2469-76. PubMed ID: 18079094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease: Edinburgh Artery Study.
    Price JF; Mowbray PI; Lee AJ; Rumley A; Lowe GD; Fowkes FG
    Eur Heart J; 1999 Mar; 20(5):344-53. PubMed ID: 10206381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein (a) and its relationship to risk factors and severity of atherosclerotic peripheral vascular disease.
    Cheng SW; Ting AC; Wong J
    Eur J Vasc Endovasc Surg; 1997 Jul; 14(1):17-23. PubMed ID: 9290555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein (a): a risk factor for peripheral vascular disease.
    Widmann MD; Sumpio BE
    Ann Vasc Surg; 1993 Sep; 7(5):446-51. PubMed ID: 8268090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for progression of peripheral arterial disease in large and small vessels.
    Aboyans V; Criqui MH; Denenberg JO; Knoke JD; Ridker PM; Fronek A
    Circulation; 2006 Jun; 113(22):2623-9. PubMed ID: 16735675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein(a) is an independent risk factor for peripheral arterial disease in Chinese type 2 diabetic patients in Taiwan.
    Tseng CH
    Diabetes Care; 2004 Feb; 27(2):517-21. PubMed ID: 14747238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein (a) in peripheral arterial occlusive disease.
    Lupattelli G; Siepi D; Pasqualini L; Ciuffetti G; Pagliaricci S; Paltriccia R; Sinzinger H; Mannarino E
    Vasa; 1994; 23(4):321-4. PubMed ID: 7817612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of obesity distribution and peripheral arterial occlusive disease in elderly men.
    Planas A; Clará A; Pou JM; Vidal-Barraquer F; Gasol A; de Moner A; Contreras C; Marrugat J
    Int J Obes Relat Metab Disord; 2001 Jul; 25(7):1068-70. PubMed ID: 11443508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homocysteine levels and peripheral arterial occlusive disease: a prospective cohort study and review of the literature.
    Asfar S; Safar HA
    J Cardiovasc Surg (Torino); 2007 Oct; 48(5):601-5. PubMed ID: 17989630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein [Lp(a)] and peripheral vascular disease.
    Tyrrell J; Cooke T; Reilly M; Colgan M; Moore D; Shanik DG; Bergin C; Feely J
    J Intern Med; 1992 Oct; 232(4):349-52. PubMed ID: 1402639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased serum lipoprotein(a) concentrations and low molecular weight phenotypes of apolipoprotein(a) are associated with symptomatic peripheral arterial disease.
    Dieplinger B; Lingenhel A; Baumgartner N; Poelz W; Dieplinger H; Haltmayer M; Kronenberg F; Mueller T
    Clin Chem; 2007 Jul; 53(7):1298-305. PubMed ID: 17525104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein (a) and lipid and non-lipid risk factors in coronaries risk assessment.
    Agoşton-Coldea L; Rusu LD; Zdrenghea D; Rusu ML; Pop D; Crăciun A; Poanta L; Gatfossé M; Rosenstingl S; Mocan T
    Rom J Intern Med; 2008; 46(2):137-44. PubMed ID: 19284085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein(a) in South Indian type 2 diabetic subjects in relation to diabetic vascular complications.
    Deepa R; Mohan A; Rema M; Haranath SP; Saravanan G; Mohan V
    J Assoc Physicians India; 2002 May; 50(5):657-61. PubMed ID: 12186119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Association between lipoprotein(a) and coronary disease].
    Bovet P; Burnand B; Kappenberger L; Riesen W; Darioli R
    Schweiz Med Wochenschr; 1993 Nov; 123(45):2138-46. PubMed ID: 8266034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cigarette smoking and peripheral arterial occlusive disease.
    Cole CW; Hill GB; Farzad E; Bouchard A; Moher D; Rody K; Shea B
    Surgery; 1993 Oct; 114(4):753-6; discussion 756-7. PubMed ID: 8211690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An elevated lipoprotein(a) plasma level as a cardiovascular risk factor.
    Tselmin S; Müller G; Gelgaft E; Fischer S; Julius U
    Atheroscler Suppl; 2015 May; 18():257-62. PubMed ID: 25936334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Elevated levels of lipoprotein(a) are present in subjects with early ischemic cardiopathy and with a familial history of ischemic cardiopathy].
    Saitta A; Castaldo M; Sardo A; Cinquegrani M; Bonaiuto M; Zema M; Gravina M; Mangano C
    Minerva Med; 1999; 90(5-6):151-8. PubMed ID: 10780189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Underrecognized peripheral arterial disease in patients with acute coronary syndrome: prevalence of traditional and emergent cardiovascular risk factors].
    Huelmos A; Jiménez J; Guijarro C; Belinchón JC; Puras E; Sánchez C; Casas ML; López-Bescos L
    Rev Esp Cardiol; 2005 Dec; 58(12):1403-10. PubMed ID: 16371199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.